Market Blog » The Arora Report Stock Market News

MASSIVE UNDERREPORTING OF VIRUS BUT HOSPITALIZATION RATE 80% LOWER WITH OMICRON

December 22, 2021

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Island Reversal Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: In yesterday’s Morning Capsule we shared with you, based on the premarket data, that an island reversal was potentially forming. The chart shows that an island reversal has actually occurred. The chart shows that island reversal led the market higher than where it was when Omicron news first broke. Omicron has done a lot of

POTENTIAL ISLAND REVERSAL PATTERN FORMING IN THE STOCK MARKET

December 21, 2021

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Island Reversal Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows that a potential island reversal pattern is forming in the stock market based on the premarket data. Only after the close, it will be known if the pattern has formed. An island reversal is a bullish pattern. If the island does form, it will be especially bullish because the pattern would

A DRAMATIC CHANGE IN THE FACTS AS OMICRON SPREADS LIKE WILDFIRE

December 20, 2021

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. A Dramatic Change Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: As omicron spreads like wildfire, investors and Wall Street continue to suffer from the recency bias. The recency bias means that the road ahead will be the same as the road behind. For investors, there is a dramatic change in facts. Analysts are not fully incorporating the new facts into their analysis due to the recency bias. Senator Manchin has stood up to President Biden and

WEEKLY STOCK MARKET DIGEST: MANCHIN STANDS UP — STOCKS GO LOWER, NEGATIVE REAL INTEREST RATES THROUGH 2022

December 18, 2021

By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report. Please scroll down for the section ‘Protection Bands and What To Do Now.’ MANCHIN STANDS UP — TECH STOCKS GO LOWER December 17, 2021 To gain an edge, this

MOMO INCURS HEAVY LOSSES ON THE WHIPSAW

December 17, 2021

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know now. Heavy Losses Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The chart shows aggressive momo buying after the Fed announcement yesterday. Take a look at charts of momo’s favorite stocks and you will find that the moves were many times more than the move in QQQ. Many momo stocks went up 8 – 25% yesterday afternoon. Smart money had started selling momo stocks right near the close yesterday. The chart shows that today smart money has continued to sell

FED PIVOTS — THREE RATE RISES IN 2022

December 16, 2021

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know now. Fed Pivots Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: The Fed has pivoted to control inflation. Here are the key points: The Fed has doubled the size of taper as expected. At the new rate of taper, money printing should stop by mid-March. The Fed is signaling three rate rises in 2022. The most important data point going forward is the terminal rate. The Fed is silent on this subject. Due to the importance of the terminal rate,

INVESTORS IGNORE THIS 60 YEAR CHART AT YOUR OWN PERIL

December 15, 2021

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Ignore At Your Own Peril Please click here for a chart of market yield on U. S. 10-year Treasuries at constant maturity less Consumer Price Index ex food and energy. Note the following: Start with Arora’s Second Law of Investing: Nobody knows with certainty what is going to happen next in the markets. Prudent investors analyze various potential scenarios in advance. The reckless money printing by the Fed and borrowing by Biden have created several realistic scenarios for the future. One

517% GAIN ON THIS ARORA MARIJUANA PORTFOLIO COMPANY

December 14, 2021

By Nigam Arora & Dr. Natasha Arora 517% Gain Congratulations! Arena Pharmaceuticals (ARNA), a biotech associated with marijuana, has received a $100 per share all-cash offer from Pfizer (PFE). ARNA is long from the original Arora buy signal from $16.20. At a $100 cash offer, it represents a gain of 517%. Arena has been in the Arora MARIJUANA MODEL PORTFOLIO. We have repeatedly flagged for our subscribers that ARNA was a buyout candidate and that was one of the reasons to buy the stock. That call has now proven spot on. To date, 169 of Arora portfolio companies have been bought out producing a fortune for long-time